Globus Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Globus Medical (GMED).

Price Target Range — 13 Quarters

Analyst Consensus — 17 Analysts

11Buy

6Hold

Consensus RatingBuy# Analysts17Avg. Consensus PT$96Upside to Avg. PT+18.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 1, 2026	RBC Capital	Kendall Au	PT Cut	Outperform	$115→$85
Aug 7, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Overweight	$103→$99
Jul 28, 2026	UBS	Matthew Taylor	Initiate	Neutral	$82
Jul 16, 2026	Truist Securities	Richard Newitter	PT Cut	Buy	$115→$100
Jul 13, 2026	RBC Capital	Shagun Singh	PT Cut	Outperform	$120→$115
Jul 9, 2026	BMO Capital	—	Initiate	Outperform	$94
Jul 8, 2026	Stifel	Tom Stephan	PT Cut	Hold	$95→$80
Jun 15, 2026	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$115→$100
May 8, 2026	RBC Capital	Shagun Singh	PT Raise	Outperform	$115→$120
May 8, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Overweight	$104→$103
May 8, 2026	Needham	David Saxon	PT Raise	Buy	$114→$117
Feb 26, 2026	Wells Fargo	Vik Chopra	PT Raise	Overweight	$98→$104
Feb 25, 2026	Barclays	Matt Miksic	PT Raise	Overweight	$118→$123
Feb 25, 2026	Needham	David Saxon	PT Raise	Buy	$112→$114
Jan 30, 2026	Needham	David Saxon	Upgrade	Hold→Buy	$112
Jan 9, 2026	Canaccord Genuity	Caitlin Cronin	PT Raise	Buy	$105→$112
Jan 8, 2026	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$90→$115
Dec 17, 2025	Canaccord Genuity	Caitlin Cronin	PT Raise	Buy	$90→$105
Dec 17, 2025	RBC Capital	Shagun Singh	PT Raise	Outperform	$92→$100
Dec 17, 2025	Freedom Capital Markets	Keith Hinton	Initiate	Hold	$87

Analyst Ratings News

PRO
RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $85

RBC Capital analyst Kendall Au maintains Globus Medical (NYSE:GMED) with a Outperform and lowers the price target from $115 to $85.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $99

Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and lowers the price target from $103 to $99.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $100

Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $115 to $100.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $115

RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and lowers the price target from $120 to $115.

Benzinga Newsdesk

PRO
BMO Capital Initiates Coverage On Globus Medical with Outperform Rating, Announces Price Target of $94

BMO Capital initiates coverage on Globus Medical (NYSE:GMED) with a Outperform rating and announces Price Target of $94.

Benzinga Newsdesk

PRO
Stifel Maintains Hold on Globus Medical, Lowers Price Target to $80

Stifel analyst Tom Stephan maintains Globus Medical (NYSE:GMED) with a Hold and lowers the price target from $95 to $80.

Benzinga Newsdesk

Globus Medical Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Globus Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $85

PRO
Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $99

PRO
Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $100

PRO
RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $115

PRO
BMO Capital Initiates Coverage On Globus Medical with Outperform Rating, Announces Price Target of $94

PRO
Stifel Maintains Hold on Globus Medical, Lowers Price Target to $80

People Also Watch

People Also Watch

Globus Medical Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Globus Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRORBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $85

PROWells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $99

PROTruist Securities Maintains Buy on Globus Medical, Lowers Price Target to $100

PRORBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $115

PROBMO Capital Initiates Coverage On Globus Medical with Outperform Rating, Announces Price Target of $94

PROStifel Maintains Hold on Globus Medical, Lowers Price Target to $80

People Also Watch

People Also Watch

PRO
RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $85

PRO
Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $99

PRO
Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $100

PRO
RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $115

PRO
BMO Capital Initiates Coverage On Globus Medical with Outperform Rating, Announces Price Target of $94

PRO
Stifel Maintains Hold on Globus Medical, Lowers Price Target to $80